A drug with the SMILES Cc1cccc(N2CCN(C(=S)Nc3ccc4nc5n(c(=O)c4c3)CCCCC5)CC2)c1C has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -15.590%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cccc(N2CCN(C(=S)Nc3ccc4nc5n(c(=O)c4c3)CCCCC5)CC2)c1C
Cc1cccc(N2CCN(C(=S)Nc3ccc4nc5n(c(=O)c4c3)CCCCC5)CC2)c1C
4-(2,3-dimethylphenyl)-N-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)piperazine-1-carbothioamide